Reveal快速药敏系统在大型城市医院革兰阴性血培养中的性能评估
Reveal与Sensititre的必需一致率为98.0%、分类一致率为96.3%、极重大误差为1.3%;与Vitek 2的EA/CA/VME分别为97.0%/96.2%/1.3%。对33株高耐药菌株的模拟血培养结果相当,平均出结果时间4.6小时,样本制备平均3分钟。结论认为Reveal系统可实现革兰阴性血培养的准确快速药敏检测。
要点
- Reveal与Sensititre的EA为98.0%、CA为96.3%、VME为1.3%。
- Reveal与Vitek 2的EA/CA/VME分别为97.0%/96.2%/1.3%。
- 高耐药菌株模拟血培养的EA/CA/VME为97.7%/95.2%/1.0%。
核心结论
- Reveal系统能够对革兰阴性血培养进行准确且快速的药敏检测。
研究设计与样本
- 另用33株高耐药菌株的模拟血培养评估性能,并与CDC/FDA抗生素耐药菌株库参考方法比较。
主要发现
- Reveal与Sensititre的必需一致率为98.0%,分类一致率为96.3%,极重大误差为1.3%。
- Reveal与Vitek 2的EA/CA/VME分别为97.0%/96.2%/1.3%。
- 对高耐药菌株模拟血培养,Reveal与CDC/FDA参考方法的EA/CA/VME分别为97.7%/95.2%/1.0%。
- Reveal平均出结果时间为4.6小时,样本制备平均耗时3分钟。
关键数值与推荐
- 与Sensititre比较:EA 98.0%,CA 96.3%,VME 1.3%。
- 与Vitek 2比较:EA 97.0%,CA 96.2%,VME 1.3%。
- 高耐药菌株模拟血培养与CDC/FDA参考比较:EA 97.7%,CA 95.2%,VME 1.0%。
- 平均出结果时间4.6小时,样本制备平均3分钟。
临床怎么用
- Reveal系统可用于革兰阴性血培养的快速药敏检测,辅助临床及时调整抗菌治疗。
- 该系统样本制备操作简单,平均3分钟即可完成,适合常规实验室开展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Timely and effective antibiotic treatment is vital for sepsis, with increasing incidence of antimicrobial-resistant bacteremia driving interest in rapid phenotypic susceptibility testing. To enable the widespread adoption needed to make an impact, antibiotic susceptibility testing (AST) systems need to be accurate, enable rapid intervention, have a broad antimicrobial menu and be easy to use and affordable. We evaluated the Specific Reveal (Specific Diagnostics, San Jose, CA) rapid AST system on positive blood cultures with Gram-negative organisms in a relatively resistant population in a large urban hospital to assess its potential for routine clinical use. One hundred four randomly selected positive blood cultures (Virtuo; bioMérieux) were Gram stained, diluted 1:1,000 in Pluronic water, inoculated into 96-well antibiotic plates, sealed with the Reveal sensor panel, and placed in the Reveal instrument for incubation and reading. The MIC and susceptible/intermediate/resistant category was determined and compared to results from Vitek 2 (bioMérieux) for the 17 antimicrobials available and to Sensititre (Thermo Fisher) for 24 antimicrobials. Performance was also assessed with contrived blood cultures with 33 highly resistant strains. Reveal was in 98.0% essential agreement (EA) and 96.3% categorical agreement (CA) with Sensititre, with just 1.3% very major error (VME) and 97.0%/96.2%/1.3% EA/CA/VME versus Vitek 2. Reveal results for contrived highly resistant strains were equivalent, with EA/CA/VME of 97.7%/95.2%/1.0% with CDC/FDA Antibiotic Resistance Isolate Bank references. Average time to result (TTR) for Reveal was 4.6 h. Sample preparation was relatively low skill and averaged 3 min. We conclude that the Reveal system enables accurate and rapid susceptibility testing of Gram-negative blood cultures.
引用
- Tibbetts R, George S, Burwell R, et al. Performance of the Reveal Rapid Antibiotic Susceptibility Testing System on Gram-Negative Blood Cultures at a Large Urban Hospital. J Clin Microbiol. 2022. PMID: 35607972. doi:10.1128/jcm.00098-22
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。